Delivery Order SPE2DE24D0013-SPE2D625F4DYH
- Not listed
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $14,448 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and will be performed at Cepheid's...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $2,244 firm fixed-price delivery order to Cepheid Inc. on August 28, 2025, for SARS-CoV-2, Flu, and RSV molecular diagnostic testing solutions. The contract, which contains no set-aside designation, carries an ultimate completion date of September 12, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order is part of Cepheid's broader federal contracting...
- The U.S. Defense Logistics Agency (Medical Supply Chain division) awarded a $4,488 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 21, 2025. The delivery order, valued at $4,488 with an ultimate completion date of September 5, 2025, is for SARS-CoV-2, Flu, and RSV testing solutions. This award utilizes no set-aside designation and represents a continuation of Cepheid's longstanding partnership with federal...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain function, awarded a $20.4K firm fixed-price delivery order to Cepheid Inc. on September 18, 2025, with a completion date of September 25, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) testing, with performance to be executed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside...
- The U.S. Defense Logistics Agency awarded a $29,478.60 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 6, 2025, with an ultimate completion date of August 13, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a relatively modest...
- The U.S. Defense Logistics Agency, through the Medical Supply Chain division, awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The delivery order addresses federal requirements for COVID-19, influenza, and respiratory syncytial virus...
- The U.S. Defense Department's Medical Supply Chain division awarded a $17,280 firm fixed-price delivery order to Cepheid Inc. on August 27, 2025, with an ultimate completion date of September 4, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus. Cepheid, a Sunnyvale, California-based manufacturer of advanced diagnostic systems and test kits, was selected without a set-aside...
- The U.S. Defense Department's Medical Supply Chain awarded a $7,480 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, on September 5, 2025, with completion targeted for September 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside designation and represents a continuation of Cepheid's...
- The U.S. Defense Logistics Agency, operating through the Medical Supply Chain function, awarded a $13,464 firm fixed-price delivery order to Cepheid Inc. on July 15, 2025, with an ultimate completion date of July 29, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, was issued without a set-aside designation and represents procurement of molecular diagnostic solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The work will be performed at Cepheid's facility...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F4DYHDelivery Order
The U.S. Defense Logistics Agency, operating under its Medical Supply Chain division, awarded a $4,488 firm fixed-price delivery order to Cepheid Inc. on September 25, 2025, with an ultimate completion date of October 9, 2025. The contract, designated as SARS-COV-2 FLU RSV 10S, procures molecular diagnostic testing solutions from the Sunnyvale, California-based manufacturer. This delivery order carries no set-aside designation and represents a discrete procurement under Cepheid's broader federal contracting relationship with defense and Veterans Affairs entities. Cepheid specializes in advanced molecular diagnostic systems and reagents for detecting infectious diseases, with particular expertise in respiratory and viral pathogens. The company maintains significant federal presence through multiple Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, including a $32.8 million single-award IDV with VA's Veterans Integrated Service Network 6 and a $2.5 million vehicle with Veterans Integrated Service Network 21, both providing diagnostic testing capabilities for conditions including COVID-19, influenza, and respiratory syncytial virus. This delivery order aligns with Cepheid's established role as a key supplier of PCR-based diagnostic solutions to federal healthcare and defense systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 9/25/25 |